H Tsuboi Selected Research

Complement System Proteins (Complement)

1/2021

Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Tsuboi Research Topics

Disease

7	Rheumatoid Arthritis 01/2021 - 03/2003
3	Arthritis (Polyarthritis) 05/2024 - 01/2018
2	Inflammation (Inflammations) 12/2018 - 01/2018
2	Necrosis 01/2018 - 04/2013
2	Hyperplasia 04/2001 - 02/2001
2	Neoplasms (Cancer) 09/2000 - 06/2000
1	Congenital Abnormalities (Deformity) 05/2024
1	Osteoporosis 08/2022
1	Postmenopausal Osteoporosis 08/2022
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2018
1	Localized Scleroderma (Morphea) 01/2018
1	Hypohidrosis 01/2018
1	Immunoglobulin G4-Related Disease 10/2017
1	Sialadenitis 02/2017
1	Experimental Arthritis 01/2017
1	Fever (Fevers) 05/2009
1	Acute-Phase Reaction 05/2009
1	Hyperhomocysteinemia 04/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001
1	Myocardial Infarction 04/2001
1	Hemorrhage 04/2001
1	Death (Near-Death Experience) 10/2000
1	Endometrial Neoplasms (Endometrial Cancer) 06/2000
1	Carcinoma (Carcinomatosis) 06/2000
1	Angina Pectoris 03/2000

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2021 - 04/2013
2	tocilizumab (atlizumab)FDA Link 12/2018 - 05/2009
2	AntibodiesIBA 01/2018 - 04/2013
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2018 - 02/2017
2	InterleukinsIBA 10/2017 - 05/2009
1	Denosumab FDA Link 08/2022
1	romosozumabIBA 08/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	inter-alpha-inhibitorIBA 01/2021
1	C-Reactive ProteinIBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	AntigensIBA 01/2018
1	Complementary DNA (cDNA)IBA 10/2017
1	CytokinesIBA 02/2017
1	Interleukin-17 (Interleukin 17)IBA 02/2017
1	InterferonsIBA 01/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2013
1	EpitopesIBA 04/2013
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 04/2013
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2009
1	Immunoglobulins (Immunoglobulin)IBA 05/2006
1	Tartrate-Resistant Acid PhosphataseIBA 03/2003
1	NucleotidesIBA 04/2001
1	HomocysteineIBA 04/2001
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2001
1	monteplaseIBA 04/2001
1	Heparin (Liquaemin)FDA LinkGeneric 04/2001
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2001
1	Quinapril (Accupril)FDA LinkGeneric 02/2001
1	N 30IBA 10/2000
1	3-chloroperbenzoic acid (meta-chloroperoxybenzoic acid)IBA 09/2000
1	Ethiodized Oil (Ethiodol)FDA Link 09/2000
1	Starch (Cornstarch)IBA 09/2000
1	anthraceneIBA 06/2000
1	Acetates (Acetic Acid Esters)FDA Link 06/2000
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 06/2000
1	AdrenomedullinIBA 03/2000

Therapy/Procedure

2	Therapeutics 12/2018 - 04/2001
1	Arthroplasty 05/2024
1	Osteotomy 05/2024
1	Thrombolytic Therapy 04/2001
1	Stents 02/2001